• Profile
Close

Progesterone receptor together with PKCα expression as prognostic factors for astrocytomas malignancy

OncoTargets and Therapy Jun 19, 2021

Arcos-Montoya D, Wegman-Ostrosky T, Mejía-Pérez S, et al. - Whether progesterone receptor (PR) phosphorylation together with protein kinase C alpha (PKCα) expression could serve as a prognostic factor for astrocytomas malignancy, was inquired in this study. Researchers analyzed 46 biopsies from Mexican patients with different astrocytoma malignancy grades, to determine the content of PKCα, PR and its phosphorylation at Ser400, using immunofluorescence. They found the presence of a positive correlation between the tumor grade and the content of PKCα, PR and its phosphorylation at Ser400, as well as the intracellular colocalization of these proteins. PR and PKCα expression at mRNA level was shown to have an inverse ratio with astrocytomas tumor grade, as revealed by employing an in silico assay. In the light of these observations, it could be considered that PR and its phosphorylation at Ser400 site, as well as PKCα and their colocalization represent possible malignancy biomarkers for astrocytomas grades I–IV.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay